[1]
“Assessing oxime reactivation efficacy using principal component analysis: Insights from nerve agents inhibited human butyrylcholinesterase: Original scientific  article”, ADMET DMPK, vol. 14, Art. no. 3361, May 2026, doi: 10.5599/admet.3361.